发明名称 N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
摘要 N-Arylphenylacetamide derivatives represented by the following formula [I]: (wherein R<SUP>1 </SUP>is C<SUB>1-6 </SUB>alkoxy, etc.; R<SUP>2 </SUP>is hydrogen, -(CH<SUB>2</SUB>)<SUB>m</SUB>-N(R<SUP>6</SUP>)(R<SUP>7</SUP>) (m is an integer of from 1 to 4; R<SUP>6 </SUP>is hydrogen, C<SUB>1-4 </SUB>alkyl, etc., R<SUP>7 </SUP>is hydrogen, etc.), etc.; R<SUP>3 </SUP>is hydrogen, halogen, etc.; R<SUP>4 </SUP>is C<SUB>6-10 </SUB>alkyl, -Y-R<SUP>8 </SUP>(Y is a single bond, C<SUB>1-6 </SUB>alkylene, C<SUB>2-6 </SUB>alkenylene, C<SUB>2-6 </SUB>alkynylene, etc., R<SUP>8 </SUP>is aryl, C<SUB>3-8 </SUB>cycloalkyl, C<SUB>6-15 </SUB>polycycloalkyl, etc.), etc.; R<SUP>5 </SUP>is hydrogen, etc.; and X<SUP>1 </SUP>is hydrogen), or pharmaceutically acceptable salts thereof or hydrates or solvates of the same, and a pharmaceutical composition containing the same. These compounds are useful as preventives and/or remedies giving no pain at the early stage of administration, which are efficacious in oral administration and have potent analgesic and antiinflammatory effects.
申请公布号 KR20040017227(A) 申请公布日期 2004.02.26
申请号 KR20037016120 申请日期 2003.12.09
申请人 发明人
分类号 C07C235/38;A61K31/167;A61K31/341;A61K31/357;A61K31/36;A61K31/381;A61K31/385;A61K31/40;A61K31/404;A61K31/4164;A61K31/426;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/445;A61K31/4453;A61K31/451;A61K31/47;A61K31/505;A61K31/5375;A61K31/55;A61P11/00;A61P13/00;A61P17/04;C07C311/08;C07C311/46;C07D233/61;C07D333/20 主分类号 C07C235/38
代理机构 代理人
主权项
地址